Manifestation of Pathology in Animal Models of Diabetic Retinopathy Is Delayed from the Onset of Diabetes
Open Access
- 28 January 2024
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (3) , 1610
Abstract
Diabetic retinopathy (DR) is the most common complication that develops in patients with diabetes mellitus (DM) and is the leading cause of blindness worldwide. Fortunately, sight-threatening forms of DR develop only after several decades of DM. This well-documented resilience to DR suggests that the retina is capable of protecting itself from DM-related damage and also that accumulation of such damage occurs only after deterioration of this resilience. Despite the enormous translational significance of this phenomenon, very little is known regarding the nature of resilience to DR. Rodent models of DR have been used extensively to study the nature of the DM-induced damage, i.e., cardinal features of DR. Many of these same animal models can be used to investigate resilience because DR is delayed from the onset of DM by several weeks or months. The purpose of this review is to provide a comprehensive overview of the literature describing the use of rodent models of DR in type-1 and type-2 diabetic animals, which most clearly document the delay between the onset of DM and the appearance of DR. These readily available experimental settings can be used to advance our current understanding of resilience to DR and thereby identify biomarkers and targets for novel, prevention-based approaches to manage patients at risk for developing DR.Keywords
Funding Information
- Illinois Society to Prevent Blindness (EY031350, EY001792)
- Retina Research Foundation (EY031350, EY001792)
- National Institutes of Health (EY031350, EY001792)
- Research to Prevent Blindness Foundation (EY031350, EY001792)
This publication has 95 references indexed in Scilit:
- Update on animal models of diabetic retinopathy: from molecular approaches to mice and higher mammalsDisease Models & Mechanisms, 2012
- Dietary wolfberry ameliorates retinal structure abnormalities in db/db mice at the early stage of diabetesExperimental Biology and Medicine, 2011
- Neurodegenerative influence of oxidative stress in the retina of a murine model of diabetesDiabetologia, 2010
- Losartan and Ozagrel Reverse Retinal Arteriolar Constriction in Non‐Obese Diabetic MiceMicrocirculation, 2008
- 5-Lipoxygenase, but Not 12/15-Lipoxygenase, Contributes to Degeneration of Retinal Capillaries in a Mouse Model of Diabetic RetinopathyDiabetes, 2008
- Neuroprotective Effects of Angiotensin II Type 1 Receptor (AT1R) Blocker, Telmisartan, via Modulating AT1R and AT2R Signaling in Retinal InflammationInvestigative Ophthalmology & Visual Science, 2006
- Lutein effect on retina and hippocampus of diabetic miceFree Radical Biology and Medicine, 2006
- The RAGE Axis in Early Diabetic RetinopathyInvestigative Ophthalmology & Visual Science, 2005
- The Ins2AkitaMouse as a Model of Early Retinal Complications in DiabetesInvestigative Ophthalmology & Visual Science, 2005
- A central role for inflammation in the pathogenesis of diabetic retinopathyThe FASEB Journal, 2004